ROS1+ NSCLC: Diagnosing and Treatment – 2022 Program: Targeted Therapies Forum

Dive deep into ROS1+ NSCLC with Dr. Alejandro Calvo. In this captivating segment from the 2022 Targeted Therapies Forum, gain a comprehensive understanding of ROS1 mutations, the diagnostic tests employed, and the cutting-edge treatment options available.

Special thanks to our esteemed sponsors for making this knowledge sharing possible: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech.

To journey further into the world of advanced cancer therapies and join in the discussion with experts and peers, explore more at http://cancerGRACE.org/ and visit our forum at https://cancergrace.org/forum.